Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Basics and practicing guidelines on phenobarbital attributes and effects

View through CrossRef
Phenobarbital has been used for many years as an anticonvulsant and sedative-hypnotic medication to treat a variety of medical disorders. Malonic acid and diethyl malonate are the main beginning ingredients used in the chemical processes that lead to the creation of phenobarbital. Peak plasma concentrations of phenobarbital are obtained within 2 to 6 hours of oral dosing and are well absorbed. Microsomal enzymes in the liver play a major role in the hepatic metabolism of phenobarbital. The primary metabolic pathway is hydroxylation, which is mostly carried out by the cytochrome P450 enzymes CYP2C9 and CYP2C19. Adults’ elimination half-lives range from 53 to 140 hours, which is a very broad range. Its primary mechanism of action is boosting the inhibitory effects of the central nervous system neurotransmitter gamma-amino butyric acid (GABA). Phenobarbital concentration in blood plasma is measured using a laboratory procedure called plasma level determination of phenobarbital. It is concluded for specific advice and direction on how to use and manage phenobarbital, one must speak with a healthcare practitioner. They have access to medical history and can offer the best advice based on particular requirements.
Title: Basics and practicing guidelines on phenobarbital attributes and effects
Description:
Phenobarbital has been used for many years as an anticonvulsant and sedative-hypnotic medication to treat a variety of medical disorders.
Malonic acid and diethyl malonate are the main beginning ingredients used in the chemical processes that lead to the creation of phenobarbital.
Peak plasma concentrations of phenobarbital are obtained within 2 to 6 hours of oral dosing and are well absorbed.
Microsomal enzymes in the liver play a major role in the hepatic metabolism of phenobarbital.
The primary metabolic pathway is hydroxylation, which is mostly carried out by the cytochrome P450 enzymes CYP2C9 and CYP2C19.
Adults’ elimination half-lives range from 53 to 140 hours, which is a very broad range.
Its primary mechanism of action is boosting the inhibitory effects of the central nervous system neurotransmitter gamma-amino butyric acid (GABA).
Phenobarbital concentration in blood plasma is measured using a laboratory procedure called plasma level determination of phenobarbital.
It is concluded for specific advice and direction on how to use and manage phenobarbital, one must speak with a healthcare practitioner.
They have access to medical history and can offer the best advice based on particular requirements.

Related Results

Clinical Pharmacology of Phenobarbital in Infants and Children
Clinical Pharmacology of Phenobarbital in Infants and Children
Phenobarbital inhibits seizures by potentiation of synaptic inhibition through an action on the GABAA receptor. Phenobarbital is an effective agent for generalized tonic-clonic foc...
The Role of Oral Phenobarbital Therapy in the Management of Neonates with Prolonged Unconjugated Hyperbilirubinemia
The Role of Oral Phenobarbital Therapy in the Management of Neonates with Prolonged Unconjugated Hyperbilirubinemia
Background: Prolonged jaundice is a type of neonatal jaundice, which occurs in infants with high bilirubin levels (>10 mg/dl) persisting beyond day 14 of life in term neonates, ...
Effects of Some Antiepileptic Drugs in Pentetrazol‐Induced Convulsions in Mice Lesioned with Kainic Acid
Effects of Some Antiepileptic Drugs in Pentetrazol‐Induced Convulsions in Mice Lesioned with Kainic Acid
Summary: Mice were injected with intracerebroventricular (i.c.v.) kainic acid (KA; 0.1/μg per animal) and the pentetrazol test was carried out on the fifth day after the administr...
Antiproliferative activity of Brassica nigra seeds extract in liver tissue of mice exposed to phenobarbital
Antiproliferative activity of Brassica nigra seeds extract in liver tissue of mice exposed to phenobarbital
Hepatocellular proliferation is one of the most common causes of hepatocellular carcinoma (HCC), a type of cancer that is widely distributed disease. Hepatocellular carcinoma treat...
Adverse effects of early phenobarbital administration in term newborns with perinatal asphyxia
Adverse effects of early phenobarbital administration in term newborns with perinatal asphyxia
Taking advantage of the lack of consensus in our neonatal unit regarding the early (prior to the onset of signs of hypoxic – ischaemic encephalopathy) administration of phenobarbit...
Phenobarbital for Long-Term Management of Marked Hyperbilirubinemia.
Phenobarbital for Long-Term Management of Marked Hyperbilirubinemia.
Abstract 5089 Gilbert's syndrome (GS) is associated with a mild chronic unconjugated hyperbilirubinemia, due to partial deficiency of bilirubin uridine diphosphate g...
Inhibition of gluconeogenesis in isolated rat hepatocytes after chronic treatment with phenobarbital
Inhibition of gluconeogenesis in isolated rat hepatocytes after chronic treatment with phenobarbital
Gluconeogenesis was studied in hepatocytes isolated from phenobarbital-pretreated rats fasted for 24 h. In closed vial incubations, glucose production from lactate (20 mmol/l) and ...

Back to Top